Sonic Healthcare Ltd (SKHCF) 14.3400 $SKHCF
Global Alcohol Breathalyzer And Drug Testing Equipment Report 2014-2020 - Market Shares, Strategies, and Forecasts
M2 - Wed Nov 26, 5:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/rf99gs/alcohol) has announced the addition of Wintergreen Research, Inc's new report "Global Alcohol Breathalyzer And Drug Testing Equipment Report 2014-2020 - Market Shares, Strategies, and Forecasts" to their offering. The drug testing segment starts out as a low 29% percent of the drug and alcohol abuse detection market in 2013 and grows to be 66% of the market by 2020 responding in part to the sheer danger of the heroin drugs. The terrorists have promised to be flooding the US with opiates and heroin, wrecking the country from the inside. This is a tremendous danger, cheap heroin. The drug testing represents a deterrent as significant as military deterrent or more so to protect the citizens from direct attack. Alternatives to bars are emerging. Sports clubs have sprung up all over, creating clubs where people can meet and interact without going to a bar. The fact that alternative socialization venues exist is making it easier to enforce laws against drinking and driving. Alcohol related accidents kill someone every 31 minutes and injure someone every 2 minutes in the US. Alcohol and drugs cause serious disruption to the workforce when present among employees. Breath and saliva contain markers that can be used to monitor alcohol abuse, drug abuse, and the health status of patients. In the U.S. nearly half of road accidents are estimated to occur due to excessive alcohol consumption and drug abuse. Similarly, the number of deaths soared by 26% in Britain due to drunk driving in 2012. Thus, alcohol enforcements remain a priority for governments across the globe. Governments of various countries are strictly enforcing safety laws and are heavily emphasizing on work safety issues. Moreover, they are compelling organizations, vehicle owners and others to install portable breath analyzers at their work places. In the global breath analysis market, the fuel cell technology segment accounted for the largest share and is anticipated to lead the market during the forecast period. The growth in this segment is attributed to technology efficiency, accuracy and the increasing popularity of breath testing devices. Key Topics: - AMP Amphetamine Testing - Alcohol Breathalyzer - BZO Benzodiazepines Testing - Breath Analyzer - Breath Test Evidence - COC Cocaine Testing - Cannabis Testing - Combination Module Testing - Drug Abuse Test Kits - Drug Identification Kits - Drug Test Key Cup - Drug Testing - Employee Alcohol and Drug Testing - Fuel Cell Sensor - Hair Drug Test Kits - Healthcare Biosensor - Healthcare Breath Diagnostic Test - K2 - Law Enforcement Testing - OPI Morphrine Testing - Oral Fluid Drug Test Kit - Personal Breathalyzer - Rapid Detect Dip Drug - Saliva Drug Test Kits - Spice - Synthetic Drug Compounds - THC Testing - Urine Drug Test Kits Market Participants: - AK Solutions - Abbott Laboratories - Alcolizer - Alcovisor - Applied Nanodetectors - Bio-Rad Laboratories - Breathalyzers - CLIAWaived - DOT Breathalyzers - EBI - Express Diagnostic - KHN Solutions LLC Bactrack Breathalyzers - Lab Corp - Ladybug Teknologies - National Patent Analytic Systems (NPAS) / Datamaster - OmegaPoint Systems - Psychemedic - Quest Products - Randox Laboratories - Rapid Detect Inc. - Rapid Exams - Roche Diagnostics - Sonic Healthcare - Test Country - Thermo Fisher Scientific - TruTouch - okyoflash - uVera Diagnostics For more information visit http://www.researchandmarkets.com/research/rf99gs/alcohol
ABT: 46.09 (+0.87)
Global Drug Abuse Testing Market Outlook 2018 - Increase in Number of Collaborations and M&A
M2 - Thu Nov 06, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/dtmmdp/global_drug_abuse) has announced the addition of the "Global Drug Abuse Testing Market 2014-2018" report to their offering. The Global Drug Abuse Testing market to grow at a CAGR of 4.71% over the period 2013-2018 To calculate the market size, the report considers the revenue generated from sales of drug abuse testing solutions, which includes drug abuse testing kits and systems. The technologies primarily considered in the report are immunoassay and chromatography. One of the major trends upcoming in the market is the increase in the number of collaborations and M&A in the market. This strategy helps vendors to expand their portfolio as well as improve the quality and performance of their products. According to the report, the rising consumption of illicit drugs is a major driver in the Global Drug Abuse Testing market as the use of illicit drugs in developed as well as in developing countries is increasing worldwide. Further, the report states that one of the key challenges that the market faces is the inability of drug abuse testing products to detect low-dose designer drugs. The detection of designer drugs such as ecstasy, Rohypnol, and LSD is very difficult. Key Vendors - Bio-Rad Laboratories - Danaher - F. Hoffmann-La Roche - Siemens - Thermo Fisher Scientific Other Prominent Vendors - Abbott Laboratories - Agilent Technologies - Alere - Biomedical Diagnostics - Branan Medical - OraSure Technologies - PerkinElmer - Psychemedics - Quest Diagnostic - Randox Laboratories - Sigma-Aldrich - Sonic Healthcare - Waters Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Overview - Market Landscape - Market Segmentation by Technique - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/dt...drug_abuse
PMD: 15.26 (-0.14), ABT: 46.09 (+0.87), A: 40.15 (+0.13), DHR: 86.81 (+0.21), PKI: 46.30 (-0.10), OSUR: 8.13 (+0.06)
DynaLIFE(DX) Seeks Information on AHS Decision to Award Australian Company Lab Services
CNW Group - Tue Oct 21, 4:17PM CDT
Clarification important for Alberta Patients
Medivo Appoints Clinical Lab Industry Leader David Bryant to Advisory Board
PRWeb - Thu Aug 21, 7:10AM CDT
Medivo, Inc., a leader in lab data and healthcare analytics, has appointed clinical lab industry leader David W. Bryant to its Advisory Board, which represents a panel of recognized leaders in the life science and health information technology sectors who provide strategic guidance to the company.
SFE: 18.54 (+0.06)
Concise Analysis of the International Clinical Laboratory Services Market - Forecast to 2019
M2 - Tue Feb 25, 5:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/zt5xj4/clinical) has announced the addition of the "Concise Analysis of the International Clinical Laboratory Services Market - Forecast to 2019" report to their offering. The clinical diagnostic tests performed by laboratories can be broadly classified into four major categories, namely, clinical chemistry, medical microbiology & cytology, human and tumour genetics and other esoteric tests. Ranging from routine blood and urine tests to high-end genetic analysis including fluorescence in situ hybridization (FISH), molecular expression testing etc., clinical laboratories offer numerous tests that help detect disease progression and abnormalities. The three major types of service providers in this market include hospital-based laboratories, clinic-based laboratories and stand-alone laboratories. The global market for clinical laboratory services is expected to record a CAGR of 5.8% during the forecast period of 2013 to 2019, to grow from a USD 162.71 billion market in 2012 to a USD 241.37 billion market in 2019. With the increasing incidence rates of debilitating conditions such as cancer, diabetes and infectious diseases, the number of patients that will opt for such tests will continue to increase in the future and thereby increase the demand for these services. Moreover, the percentage of aged population in the U.S. is expected to grow to an estimated 20% by 2030. Such a large population of elderly people in the U.S. alone will lead to high testing volumes for clinical laboratories. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Clinical Laboratory Services Market, By Test Type, 2011 - 2019 (USD Billion) 5 Global Clinical Laboratory Services Market, By Service Provider, 2011 - 2019 (USD Billion) 6 Global Clinical Laboratory Services Market, By Geography, 2011 - 2019 (USD Billion) 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - ARUP Laboratories - Abbott Laboratories - Bio-Reference Laboratories - Bioscientia Healthcare - Charles River Laboratories - Genoptix Medical Laboratory - Healthscope Ltd - Labco SA - Laboratory Corporation Of America Holdings (Labcorp) - Quest Diagnostics, Inc - Sonic Healthcare Limited - Spectra Laboratories For more information visit http://www.researchandmarkets.com/research/zt5xj4/clinical
ABT: 46.09 (+0.87), BRLI: 34.63 (+0.06), DGX: 71.68 (+0.03), LH: 116.90 (+0.06), MCRL: 14.63 (+0.03)
Global Alcohol Breathalyzer And Drug Testing Equipment Report 2014-2020 - Market Shares, Strategies, and Forecasts
M2 - Wed Nov 26, 5:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/rf99gs/alcohol) has announced the addition of Wintergreen Research, Inc's new report "Global Alcohol Breathalyzer And Drug Testing Equipment Report 2014-2020 - Market Shares, Strategies, and Forecasts" to their offering. The drug testing segment starts out as a low 29% percent of the drug and alcohol abuse detection market in 2013 and grows to be 66% of the market by 2020 responding in part to the sheer danger of the heroin drugs. The terrorists have promised to be flooding the US with opiates and heroin, wrecking the country from the inside. This is a tremendous danger, cheap heroin. The drug testing represents a deterrent as significant as military deterrent or more so to protect the citizens from direct attack. Alternatives to bars are emerging. Sports clubs have sprung up all over, creating clubs where people can meet and interact without going to a bar. The fact that alternative socialization venues exist is making it easier to enforce laws against drinking and driving. Alcohol related accidents kill someone every 31 minutes and injure someone every 2 minutes in the US. Alcohol and drugs cause serious disruption to the workforce when present among employees. Breath and saliva contain markers that can be used to monitor alcohol abuse, drug abuse, and the health status of patients. In the U.S. nearly half of road accidents are estimated to occur due to excessive alcohol consumption and drug abuse. Similarly, the number of deaths soared by 26% in Britain due to drunk driving in 2012. Thus, alcohol enforcements remain a priority for governments across the globe. Governments of various countries are strictly enforcing safety laws and are heavily emphasizing on work safety issues. Moreover, they are compelling organizations, vehicle owners and others to install portable breath analyzers at their work places. In the global breath analysis market, the fuel cell technology segment accounted for the largest share and is anticipated to lead the market during the forecast period. The growth in this segment is attributed to technology efficiency, accuracy and the increasing popularity of breath testing devices. Key Topics: - AMP Amphetamine Testing - Alcohol Breathalyzer - BZO Benzodiazepines Testing - Breath Analyzer - Breath Test Evidence - COC Cocaine Testing - Cannabis Testing - Combination Module Testing - Drug Abuse Test Kits - Drug Identification Kits - Drug Test Key Cup - Drug Testing - Employee Alcohol and Drug Testing - Fuel Cell Sensor - Hair Drug Test Kits - Healthcare Biosensor - Healthcare Breath Diagnostic Test - K2 - Law Enforcement Testing - OPI Morphrine Testing - Oral Fluid Drug Test Kit - Personal Breathalyzer - Rapid Detect Dip Drug - Saliva Drug Test Kits - Spice - Synthetic Drug Compounds - THC Testing - Urine Drug Test Kits Market Participants: - AK Solutions - Abbott Laboratories - Alcolizer - Alcovisor - Applied Nanodetectors - Bio-Rad Laboratories - Breathalyzers - CLIAWaived - DOT Breathalyzers - EBI - Express Diagnostic - KHN Solutions LLC Bactrack Breathalyzers - Lab Corp - Ladybug Teknologies - National Patent Analytic Systems (NPAS) / Datamaster - OmegaPoint Systems - Psychemedic - Quest Products - Randox Laboratories - Rapid Detect Inc. - Rapid Exams - Roche Diagnostics - Sonic Healthcare - Test Country - Thermo Fisher Scientific - TruTouch - okyoflash - uVera Diagnostics For more information visit http://www.researchandmarkets.com/research/rf99gs/alcohol
ABT: 46.09 (+0.87)
Global Drug Abuse Testing Market Outlook 2018 - Increase in Number of Collaborations and M&A
M2 - Thu Nov 06, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/dtmmdp/global_drug_abuse) has announced the addition of the "Global Drug Abuse Testing Market 2014-2018" report to their offering. The Global Drug Abuse Testing market to grow at a CAGR of 4.71% over the period 2013-2018 To calculate the market size, the report considers the revenue generated from sales of drug abuse testing solutions, which includes drug abuse testing kits and systems. The technologies primarily considered in the report are immunoassay and chromatography. One of the major trends upcoming in the market is the increase in the number of collaborations and M&A in the market. This strategy helps vendors to expand their portfolio as well as improve the quality and performance of their products. According to the report, the rising consumption of illicit drugs is a major driver in the Global Drug Abuse Testing market as the use of illicit drugs in developed as well as in developing countries is increasing worldwide. Further, the report states that one of the key challenges that the market faces is the inability of drug abuse testing products to detect low-dose designer drugs. The detection of designer drugs such as ecstasy, Rohypnol, and LSD is very difficult. Key Vendors - Bio-Rad Laboratories - Danaher - F. Hoffmann-La Roche - Siemens - Thermo Fisher Scientific Other Prominent Vendors - Abbott Laboratories - Agilent Technologies - Alere - Biomedical Diagnostics - Branan Medical - OraSure Technologies - PerkinElmer - Psychemedics - Quest Diagnostic - Randox Laboratories - Sigma-Aldrich - Sonic Healthcare - Waters Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Overview - Market Landscape - Market Segmentation by Technique - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/dt...drug_abuse
PMD: 15.26 (-0.14), ABT: 46.09 (+0.87), A: 40.15 (+0.13), DHR: 86.81 (+0.21), PKI: 46.30 (-0.10), OSUR: 8.13 (+0.06)
DynaLIFE(DX) Seeks Information on AHS Decision to Award Australian Company Lab Services
CNW Group - Tue Oct 21, 4:17PM CDT
Clarification important for Alberta Patients
Medivo Appoints Clinical Lab Industry Leader David Bryant to Advisory Board
PRWeb - Thu Aug 21, 7:10AM CDT
Medivo, Inc., a leader in lab data and healthcare analytics, has appointed clinical lab industry leader David W. Bryant to its Advisory Board, which represents a panel of recognized leaders in the life science and health information technology sectors who provide strategic guidance to the company.
SFE: 18.54 (+0.06)
Concise Analysis of the International Clinical Laboratory Services Market - Forecast to 2019
M2 - Tue Feb 25, 5:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/zt5xj4/clinical) has announced the addition of the "Concise Analysis of the International Clinical Laboratory Services Market - Forecast to 2019" report to their offering. The clinical diagnostic tests performed by laboratories can be broadly classified into four major categories, namely, clinical chemistry, medical microbiology & cytology, human and tumour genetics and other esoteric tests. Ranging from routine blood and urine tests to high-end genetic analysis including fluorescence in situ hybridization (FISH), molecular expression testing etc., clinical laboratories offer numerous tests that help detect disease progression and abnormalities. The three major types of service providers in this market include hospital-based laboratories, clinic-based laboratories and stand-alone laboratories. The global market for clinical laboratory services is expected to record a CAGR of 5.8% during the forecast period of 2013 to 2019, to grow from a USD 162.71 billion market in 2012 to a USD 241.37 billion market in 2019. With the increasing incidence rates of debilitating conditions such as cancer, diabetes and infectious diseases, the number of patients that will opt for such tests will continue to increase in the future and thereby increase the demand for these services. Moreover, the percentage of aged population in the U.S. is expected to grow to an estimated 20% by 2030. Such a large population of elderly people in the U.S. alone will lead to high testing volumes for clinical laboratories. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Clinical Laboratory Services Market, By Test Type, 2011 - 2019 (USD Billion) 5 Global Clinical Laboratory Services Market, By Service Provider, 2011 - 2019 (USD Billion) 6 Global Clinical Laboratory Services Market, By Geography, 2011 - 2019 (USD Billion) 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - ARUP Laboratories - Abbott Laboratories - Bio-Reference Laboratories - Bioscientia Healthcare - Charles River Laboratories - Genoptix Medical Laboratory - Healthscope Ltd - Labco SA - Laboratory Corporation Of America Holdings (Labcorp) - Quest Diagnostics, Inc - Sonic Healthcare Limited - Spectra Laboratories For more information visit http://www.researchandmarkets.com/research/zt5xj4/clinical
ABT: 46.09 (+0.87), BRLI: 34.63 (+0.06), DGX: 71.68 (+0.03), LH: 116.90 (+0.06), MCRL: 14.63 (+0.03)
